Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)

G.J. Ossenkoppele, G. Stussi, J. Maertens, K. van Montfort, B.J. Biemond, D. Breems, A Ferrant, C. Graux, G.E. de Greef, C.J.M. Halkes, M. Hoogendoorn, R.M. Hollestein, M. Jongen-Lavrencic, M.D. Levin, A.A. van de Loosdrecht, M. van Marwijk-Kooij, Y. van Norden, T. Pabst, H.C. Schouten, E. VellengaG.E.G. Verhoef, O. de Weerdt, P. Wijermans, J.R. Passweg, B. Lowenberg

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)4706-4711
JournalBlood
Volume120
Issue number24
DOIs
Publication statusPublished - 2012

Cite this